221/401US=11-B / Quimioterapia
Macvicar GR, Bradley DA, Hussain M. Chemotherapy of genitourinary cancers. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 424-46. ISBN 978-0-7817-7328-7.

QUIMIOTERAPIA; CANCER GENITURINARIO; CANCER DE PROSTATA; CANCER DE BEXIGA; CANCER DE TESTICULO; CANCER DE RIM


222/401US=13 / Psco/Psq
Hallak J, Cocuzza M, Nahas WC. Câncer de próstata e de testículo. In: Carvalho VA, Franco MHP, Kovács MJ, Liberato R, Macieira RC, Veit MT, Gomes MJB, Holtz L. Temas em psico-oncologia. São Paulo: Summus, 2008. p. 52-8. ISBN 85-3230383-7.

CANCER DE PROSTATA; CANCER DE TESTICULO


223/401US=13 / Estatística
Mucci LA, Signorello LB, Adami HO. Prostate cancer. In: Adami HO, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. 2nd ed. Oxford: University Press, 2008. p. 517-54. (Monographs in Epidemiology and Biostatistics) ISBN 978-0-19-531117-4.

CANCER DE PROSTATA; CANCER DE PROSTATA. FATORES DE RISCO


224/401US=14 / Câncer
Plowman PN. Recent london improvements in curative radiation therapy for relevant early prostate cancer. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 257-66. ISBN 978-1-57331-700-9.

CANCER DE PROSTATA; RADIOTERAPIA DE INTENSIDADE MODULADA


225/401US=14 / Câncer
Hammad FT. Radical prostatectomy. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 267-77. ISBN 978-1-57331-700-9.

CANCER DE PROSTATA; PROSTATECTOMIA RADICAL; RESULTADOS ONCOLOGICOS


226/401US=14 / Radioterapia
Chung HT. Prostate cancer. In: Lu JJ, Brady LW. Radiation oncology: an evidence-based approach. New York: Springer, 2008. p. 299-319. (Medical radiology: diagnosis imaging and radiation oncology series editors; AL Baert, LW Brady, HP Heilmann, Knauth M, M Molls, C Nieder) ISBN 978-3-540-77384-9.

CANCER DE PROSTATA; CANCER DE PROSTATA LOCALIZADO. TRATAMENTO


227/401US=25 / Urologia
Sakr W. Defining the problem: from subclinical disease to clinically insignificant prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 1-11. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

CANCER DE PROSTATA; SUBCLINICA PROSTATA


228/401US=25 / Urologia
Stamey TA, Nolley R, Torti D. What every patient should know about prostate cancer before he submits to biopsy of his prostate. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 13-27. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

CANCER DE PROSTATA; BIOPSIA DA PROSTATA


229/401US=25 / Urologia
Brand TC, Thompson IM. Prostate cancer screening: navigating the controversy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 71-82. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

RASTREIO DO CANCER DA PROSTATA; CANCER DE PROSTATA; ANTIGENIO ESPECIFICO DA PROSTATA; PREVENCAO


230/401US=25 / Urologia
Terris MK. Principles of prostate ultrasound. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 105-19. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

PRINCIPIOS DE ULTRA-SOM DE PROSTATA; CANCER DE PROSTATA. ULTRA-SOM; CANCER DE PROSTATA. HIPOECOICA; CANCER DE PROSTATA. IMAGEM; CANCER DE PROSTATA


231/401US=25 / Urologia
Fitzsimons NJ, Bañez LL, Sun LL, Moul JW. Future directions in prostate cancer diagnosis. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 287-312. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

DIAGNOSTICO DE CANCER DE PROSTATA; CANCER DE PROSTATA; BLINDAGEM; PSA; BIOIMAGING BIOMARCADOR


232/401US=35 / Biol/Mol
Greene KL, Li LC, Okino ST, Carroll PR. Molecular basis of prostate cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 431-40. ISBN 978-1-4160-3703-3.

CANCER DE PROSTATA; BIOLOGIA MOLECULAR; GRAU DE GLEASON; NEOPLASIA INTRAEPITELIAL PROSTATICA DE ALTO GRAU; PATOLOGIA MOLECULAR; MICRO-RNA


233/401US=23-A / Câncer
Gwyther SJ. Detection of recurrent cancer by radiological imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 17-37. ISBN 978-1-4020-8441-62.

CANCER. DIAGNOSTICO; IMAGEM; RADIOLOGIA; CANCER DE PULMAO; CANCER DE MAMA; CANCER COLORRETAL; LINFOMA; CANCER PANCREATICO; CANCER DE PROSTATA; CANCER DE ESOFAGO; CANCER DE OVARIO; CANCER DE ENDOMETRIO; CANCER CERVICAL; CANCER DE CABECA E PESCOCO; CANCER DE TIREOIDE; TUMORES INTRACRANIANOS PRIMARIO


234/401US=23-A / Câncer
Hayat MA. Prostate carcinoma. In: ___. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 391-6. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA


235/401US=23-A / Câncer
Franklin RB, Costello LC. The role of intermediary metabolism and molecular genetics in prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 397-413. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; METABOLISMO INTERMEDIARIO; GENETICA MOLECULAR; CITRATO; M-ACONITASE; ZINCO; GLUCOSE; ASPARTATO; OXALACETATO; BIOENERGETICOS; LIPOGENESE


236/401US=23-A / Câncer
Ribeiro FR, Skotheim RI, Henrique R, Teixeira MR. Array-based comparative genomic hybridization in prostate cancer: research and clinical applications. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 415-29. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; HIBRIDIZACAO GENOMICA COMPARATIVA


237/401US=23-A / Câncer
Lu S. Prostate cancer: role of Vav3 overexpression in development and progression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 431-9. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; PROTEINA VAV3


238/401US=23-A / Câncer
Dakubo GD, Parr RL, Jakupciak JP. Prostate cancer: detection and monitoring using mitochondrial mutations as a biomarker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 441-64. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; CANCER DE PROSTATA. DIAGNOSTICO; MUTACAO MITOCONDRIAL; BIOMARCADOR; GENETICA MITOCONDRIAL; BIOENERGETICA MITOCONDRIAL; ONCOLOGIA; METABOLISMO CELULAR; MUTACAO DE DNA


239/401US=23-A / Câncer
El-Sharkawy SL, Abbas NF, El-Hefnawy NG. Prognostic markers in prostatic carcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 465-79. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; MARCADORES PROGNOSTICOS; CARCINOMA DA PROSTATA


240/401US=23-A / Câncer
Schwarzenbach H, Pantel K. Prostate cancer: detection of free tumor-specific DNA in blood and bone marrow. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 481-97. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; DNA; SANGUE; MEDULA OSSEA; GENETICA; EPIGENETICA; CELULAS DE ACIDOS NUCLEICOS; PLASMA; ANALISE DE MICROSSATELITES; POLIMORFISMOS DE UM UNICO NUCLEOTIDEO; PCR BASEADA FLUORESCENCIA


Primeira | Anterior | Próxima | Última